World's Best Scientists 2026 revealed!
Stephan Rosenkranz

Stephan Rosenkranz

D-Index & Metrics

Medicine

D-Index
86
Citations
35695
World Ranking
13925
National Ranking
736

Overview

Stephan Rosenkranz is affiliated with the University of Cologne in Germany and has an extensive publication record primarily in the fields of medicine, with a particular focus on pulmonary and respiratory medicine as well as cardiology and cardiovascular medicine. Their research spans various subfields including internal medicine, genetics, and epidemiology.

The main topics covered in Rosenkranz's work include:

  • Pulmonary Hypertension Research and Treatments
  • Cardiovascular Function and Risk Factors
  • Heart Failure Treatment and Management
  • Cardiovascular Issues in Pregnancy
  • Venous Thromboembolism Diagnosis and Management
  • Vascular Anomalies and Treatments
  • Liver Disease and Transplantation

Rosenkranz has contributed to numerous publications in reputable medical journals, with frequent appearances in:

  • European Heart Journal
  • European Respiratory Journal
  • The Journal of Heart and Lung Transplantation
  • CHEST Journal
  • Pulmonary Circulation

Some of the recent notable papers associated with this researcher include:

  • "2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension," published in 2022 in the European Heart Journal
  • "COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up," published in 2020 in the Journal of the American College of Cardiology
  • "2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension," published in 2022 in the European Respiratory Journal
  • "Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study," published in 2021 in The Lancet Regional Health - Europe
  • "Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension," published in 2023 in the New England Journal of Medicine

Collaboration forms a significant part of Rosenkranz's research activities. Frequent co-authors include:

  • Hossein Ardeschir Ghofrani
  • Marius M. Hoeper
  • Ekkehard Grünig
  • Anton Vonk Noordegraaf
  • Stephan Baldus

Best Publications

  • COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

    Behnood Bikdeli;Mahesh V. Madhavan;David Jimenez;Taylor Chuich

  • TGF-β1 and angiotensin networking in cardiac remodeling

    Stephan Rosenkranz

  • Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study.

    Max Augustin;Philipp Schommers;Melanie Stecher;Felix Dewald

  • Left ventricular heart failure and pulmonary hypertension.

    Stephan Rosenkranz;J. Simon R. Gibbs;J. Simon R. Gibbs;Rolf Wachter;Teresa De Marco

  • Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model

    Marius M Hoeper;Tilmann Kramer;Zixuan Pan;Christina A Eichstaedt

  • Pulmonary arterial hypertension: epidemiology and registries

    Michael D. McGoon;Raymond L. Benza;Pilar Escribano-Subias;Xin Jiang

  • Estrogen Modulates AT1 Receptor Gene Expression In Vitro and In Vivo

    Georg Nickenig;Anselm T. Bäumer;Christian Grohè;Stefan Kahlert

  • Pulmonary hypertension due to left heart disease.

    Jean Luc Vachiéry;Ryan J. Tedford;Stephan Rosenkranz;Massimiliano Palazzini

  • Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: Results from the COMPERA registry

    Marius M. Hoeper;Doerte Huscher;H. Ardeschir Ghofrani;Marion Delcroix

  • Anticoagulation and Survival in Pulmonary Arterial Hypertension Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)

    Karen M. Olsson;Marion Delcroix;H. Ardeschir Ghofrani;Henning Tiede

  • Alterations of β-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-β1

    Stephan Rosenkranz;Markus Flesch;Kerstin Amann;Claudia Haeuseler

  • Optimizing Engineered Heart Tissue for Therapeutic Applications as Surrogate Heart Muscle

    Hiroshi Naito;Ivan Melnychenko;Michael Didié;Karin Schneiderbanger

  • Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study.

    Diana Bonderman;Ingrid Pretsch;Regina Steringer-Mascherbauer;Pavel Jansa

  • Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum

    Christian F. Opitz;Marius M. Hoeper;J. Simon R. Gibbs;Harald Kaemmerer

  • Evidence for distinct signaling properties and biological responses induced by the PDGF receptor alpha and beta subtypes

    Stephan Rosenkranz;Andrius Kazlauskas

  • Safety and Efficacy of Exercise Training in various forms of Pulmonary Hypertension

    Ekkehard Grünig;Mona Lichtblau;Nicola Ehlken;Hossein A Ghofrani

  • Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.

    Hossein Ardeschir Ghofrani;Hossein Ardeschir Ghofrani;Gérald Simonneau;Gérald Simonneau;Andrea M. D'Armini;Peter Fedullo

  • Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial

    Nicola Ehlken;Mona Lichtblau;Hans Klose;Johannes Weidenhammer

  • An official European Respiratory Society statement: pulmonary haemodynamics during exercise

    Gabor Kovacs;Philippe Herve;Joan Albert Barbera;Ari Chaouat

  • Guía ESC/ERS 2015 sobre diagnóstico y tratamiento de la hipertensión pulmonar

    Nazzareno Galiè;Marc Humbert;Jean Luc Vachiery;Simon Gibbs

Frequent Co-Authors

Marius M. Hoeper
Marius M. Hoeper Hannover Medical School
Hossein Ardeschir Ghofrani
Hossein Ardeschir Ghofrani University of Giessen
Erland Erdmann
Erland Erdmann University of Cologne
Stephan Baldus
Stephan Baldus University of Cologne
Gérald Simonneau
Gérald Simonneau University of Paris-Saclay
Horst Olschewski
Horst Olschewski Medical University of Graz
Ralph T. Schermuly
Ralph T. Schermuly University of Giessen
Stavros Konstantinides
Stavros Konstantinides Democritus University of Thrace
Marc Humbert
Marc Humbert University of Paris-Saclay
Oliver Distler
Oliver Distler University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a medical career in the USA but want flexible study options, many affordable nursing degrees can be pursued online. For those new to healthcare, there are a range of online nursing programs that open doors to entry-level roles in hospitals, clinics, and community settings.

Registered nurses (RNs) looking to advance can explore the cheapest accredited online RN to BSN programs. These bridge courses help RNs earn their BSN quickly and affordably, which can improve job prospects and earning potential.

For career changers with non-nursing backgrounds, online direct entry MSN degrees allow you to transition into advanced practice by earning both RN licensure and a master’s degree in one streamlined program.

Already an experienced nurse? Enhance your credentials and move into education, research, or leadership with an online PhD in nursing. Online learning makes it easier to upskill without putting your career on hold, supporting a variety of pathways in healthcare and medicine.

Best Scientists Citing Stephan Rosenkranz

Trending Scientists